Correlation Between Acrivon Therapeutics, and Rocket Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Rocket Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Rocket Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Rocket Pharmaceuticals, you can compare the effects of market volatilities on Acrivon Therapeutics, and Rocket Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Rocket Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Rocket Pharmaceuticals.
Diversification Opportunities for Acrivon Therapeutics, and Rocket Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and Rocket is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Rocket Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rocket Pharmaceuticals and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Rocket Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rocket Pharmaceuticals has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Rocket Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Rocket Pharmaceuticals
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.62 times more return on investment than Rocket Pharmaceuticals. However, Acrivon Therapeutics, is 1.62 times more volatile than Rocket Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Rocket Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1,227 in Acrivon Therapeutics, Common on September 2, 2024 and sell it today you would lose (469.00) from holding Acrivon Therapeutics, Common or give up 38.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Rocket Pharmaceuticals
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Rocket Pharmaceuticals |
Acrivon Therapeutics, and Rocket Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Rocket Pharmaceuticals
The main advantage of trading using opposite Acrivon Therapeutics, and Rocket Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Rocket Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rocket Pharmaceuticals will offset losses from the drop in Rocket Pharmaceuticals' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Rocket Pharmaceuticals vs. Uniqure NV | Rocket Pharmaceuticals vs. Rhythm Pharmaceuticals | Rocket Pharmaceuticals vs. Solid Biosciences LLC | Rocket Pharmaceuticals vs. MeiraGTx Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |